Literature DB >> 1654500

Publicly funded HIV counseling and testing--United States, 1990.

.   

Abstract

A critical component of CDC's national human immunodeficiency virus (HIV)-prevention program is support for HIV counseling and testing (CT) services. Sixty-five HIV-prevention programs are in health departments in 50 states, the District of Columbia, six cities, and eight territories. Each calendar quarter, the programs report to CDC aggregate or client record data about the number of 1) pretest counseling sessions, HIV-antibody tests, positive tests, and posttest counseling sessions, by CT site; 2) HIV-antibody tests and positive tests, by self-reported risk category; and 3) HIV-antibody tests and positive tests, by age group, sex, and race/ethnicity. This report summarizes data reported for 1990.

Entities:  

Mesh:

Year:  1991        PMID: 1654500

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  4 in total

1.  Trends in HIV seroprevalence, AIDS and prevention policy among intravenous drug users and men who have sex with men, before and after 1990 in Austria.

Authors:  F Piribauer; W Duer
Journal:  Eur J Epidemiol       Date:  1998-10       Impact factor: 8.082

2.  Community-wide HIV counselling and testing in central Massachusetts: who is retested and does their behavior change?

Authors:  J McCusker; G Willis; M McDonald; S M Sereti; B F Lewis; J L Sullivan
Journal:  J Community Health       Date:  1996-02

3.  Receipt of recommended medical care in HIV-infected and at-risk persons.

Authors:  R Marx; M H Katz; A I Barreto; M S Park; T Black; M Welch
Journal:  J Gen Intern Med       Date:  1995-02       Impact factor: 5.128

4.  Predictors of refusal of provider initiated HIV testing among clients visiting adult outpatient departments in Jimma town, Oromia Region, Ethiopia: unmatched case control study.

Authors:  Yohannes Kebede Lemu; Zewdie Birhanu Koricha; Lakew Abebe Gebretsadik; Ameyu Godesso Roro
Journal:  HIV AIDS (Auckl)       Date:  2012-08-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.